Rephonic
Artwork for Post-Hoc Live

Post-Hoc Live

Endpoints News
FDA
Biotech
Biopharma
China
Biotechnology
Trump Administration
Pfizer
Mergers and Acquisitions
Novo Nordisk
Sarepta
Pharmaceuticals
ACIP
Most Favored Nation Pricing
Duchenne Muscular Dystrophy
Clinical Trials
S&P Biotech Index
CRISPR Gene Editing
Moderna
Drug Discovery
Drug Pricing

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscr... more

PublishesTwice monthlyEpisodes42Foundeda year ago
Number of ListenersCategory
News

Listen to this Podcast

Artwork for Post-Hoc Live

Latest Episodes

CEO pay keeps going up, and up, and up. What do the pay ratios at pharmas say about the state of the industry as a whole, and how do the eye-popping numbers affect global competition? On Post-Hoc Live, we’ll take you behind the scenes of Endpoints’ a... more

Jeremy Levin has seen the biopharma industry from practically every vantage point. Now, with decades of experience under his belt, he’s out front in the chorus of veterans sounding the alarm about threats to US dominance in biotech. He joins Post-Hoc... more

Marty Makary resigned as FDA commissioner on Tuesday after a turbulent tenure at the head of the agency. The Endpoints and Financial Times teams sat down at the US Pharma and Biotech Summit on Thursday to talk about his tenure, his downfall, and wher... more

Thanks to our premium subscribers who joined us live for this special episode of Post-Hoc Live. Catch up on the recording now:Are more deals coming, after a deal-heavy Q1? How are IRA negotiations and MFN deals affecting outlooks? What's the state of... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Invest Like the Best with Patrick O'Shaughnessy
Invest Like the Best with Patrick O'ShaughnessyColossus | Investing & Business Podcasts

Recent Guests

Noubar Afeyan
CEO and founder of Flagship Pioneering
Flagship Pioneering
Episode: Post-Hoc Live, Live! at #JPM26 with Noubar Afeyan
Tarek Rabah
President and CEO of Otsuka North America Pharmaceutical
Otsuka Pharmaceuticals
Episode: Post-Hoc Live, Live! at #JPM26 with Noubar Afeyan
Holly Fernandez Lynch
Assistant Professor of Medical Ethics and FDA expert
University of Pennsylvania
Episode: Fewer drugs, more chaos: One year under the new FDA
Zach Brennan
Senior Editor covering the FDA
Endpoints News
Episode: Fewer drugs, more chaos: One year under the new FDA
Andy Dunn
Biotech Correspondent
Endpoints News
Episode: Biopharma’s Winners and Losers of 2025
Lydia Ramsey-Flander
Health Tech Lead
Endpoints News
Episode: Biopharma’s Winners and Losers of 2025
Derek Lowe
Chemist, columnist, and blogger known for his insights in biopharma.
In the Pipeline blog
Episode: Reality check-ing biotech — with Derek Lowe
Hannah Kuchler
Global Pharma Editor at the Financial Times
Financial Times
Episode: M&A, MFN, and the view from the UK — with the FT’s Hannah Kuchler
Kiran Musunuru
University of Pennsylvania scientist involved in CRISPR gene editing
University of Pennsylvania
Episode: The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas

Host

Drew Armstrong
Executive Editor of Endpoints News and host of Post-Hoc Live; provides front-line reporting and synthesis of biotech policy, regulation, and market dynamics.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#228
Hong Kong/News
Apple Podcasts
#239
China/News

Talking Points

Recent interactions between the hosts and their guests.

Post-Hoc Live, Live! at #JPM26 with Noubar Afeyan
Q: What do you think about the competition from China?
Afeyan argues that competition can be beneficial if it's on a fair basis, but highlights concerns over the current landscape where advantages may favor less regulated environments.
Post-Hoc Live, Live! at #JPM26 with Noubar Afeyan
Q: Why do you think the industry is not yet speaking out in the terms that you are?
Afeyan believes that the industry tends to take certain scientific advances for granted and is not yet vocal enough about the potential risks they face.
Biopharma’s Winners and Losers of 2025
Q: What do you think that tells us about where this is all going regarding gene editing technologies?
There is anticipation for regulatory clarity on how to speed treatments like gene editing forward, especially as seen with Baby KJ.
Biopharma’s Winners and Losers of 2025
Q: What do you think Pfizer is hoping for as a bit of a holiday present out of this thing?
Pfizer is pretty confident and is hoping for successful trials next year in obesity, having seen data that gives them confidence.
The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas
Q: What have you proposed to the FDA to streamline this process?
The researchers proposed leveraging preclinical IND-enabling studies for multiple mutations to save resources and time while ensuring safety.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Post-Hoc Live

What is Post-Hoc Live about and what kind of topics does it cover?

A rigorous business-and-policy-focused show that crowdsources fast-moving biotech and healthcare topics through live reporting and expert commentary. Episodes frequently center on regulatory dynamics (FDA decisions, policy shifts), biotech industry strategy (drug development, M&A, obesity therapies, CRISPR), and market implications for investors and professionals. Guests range from FDA and policy experts to top biotech executives, journalists, and researchers, creating a clear emphasis on how policy, regulation, and market forces shape scientific progress and commercial success. The format benefits listeners who want sharp, data-informed takes from reporters and industry insiders, often tied to timely events like regulatory letters, major b... more

Where can I find podcast stats for Post-Hoc Live?

Rephonic provides a wide range of podcast stats for Post-Hoc Live. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Post-Hoc Live and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Post-Hoc Live get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Post-Hoc Live, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Post-Hoc Live?

Rephonic provides comprehensive predictive audience data for Post-Hoc Live, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Post-Hoc Live have?

To see how many followers or subscribers Post-Hoc Live has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Post-Hoc Live?

These podcasts share a similar audience with Post-Hoc Live:

1. The Readout Loud
2. Biotech Hangout
3. BioCentury This Week
4. The Long Run with Luke Timmerman
5. Invest Like the Best with Patrick O'Shaughnessy

How many episodes of Post-Hoc Live are there?

Post-Hoc Live launched a year ago and published 42 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Post-Hoc Live?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Post-Hoc Live?

Rephonic pulls ratings and reviews for Post-Hoc Live from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Post-Hoc Live?

Rephonic provides full transcripts for episodes of Post-Hoc Live. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Post-Hoc Live?

Recent guests on Post-Hoc Live include:

1. Noubar Afeyan
2. Tarek Rabah
3. Holly Fernandez Lynch
4. Zach Brennan
5. Andy Dunn
6. Lydia Ramsey-Flander
7. Derek Lowe
8. Hannah Kuchler

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days